Abstract:Background: Proline-rich transmembrane protein 2 (PRRT2) plays an important role in the central nervous system and mutations in the gene are implicated in a variety of neurological disorders. This study aimed to summarize the clinical characteristics and gene expression analysis of neurological diseases related to the PRRT2 gene and explore the clinical characteristics, therapeutic effects, and possible pathogenic mechanisms of related diseases. Methods: We enrolled 10 children with PRRT2 mutation-related neurological diseases who visited the Children's Hospital affiliated with the Shanghai Jiaotong University School of Medicine/Shanghai Children's Hospital between May 2017 and February 2022. Video electroencephalography (VEEG), cranial imaging, treatment regimens, gene results, and gene expression were analyzed. Genetic testing involved targeted sequencing or whole-exome genome sequencing (WES). We further analyzed the expression and mutation conservation of PRRT2 and synaptosome-associated protein 25 (SNAP25) in blood samples using quantitative polymerase chain reaction (qPCR) and predicted the protein structure. Summary analysis of the reported gene maps and domains was also performed. Results: Ten children with PRRT2 gene mutations were analyzed, and 4 mutations were identified, consisting of 2 new (c.518A > C, p.Glu173 Ala; c.879 + 112G > A, p.?) and two known (c. 649 dup, p. Arg217Profs * 8; c. 649 del, p. Arg217Glufs * 12) mutations. Among these mutations, one was de novo (P6), and three could not be determined because one parent refused genetic testing. The clinical phenotypes were paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), epilepsy, infantile spasms, and intellectual disability. The qPCR results showed that PRRT2 gene expression levels were significantly lower in children and parent carriers than the control group. The SNAP25 gene expression level of affected children was significantly lower ( P ≤ 0.001) than that of the control group. The mutation sites reported in this study are highly conserved in different species. Among the various drugs used, oxcarbazepine and sodium valproate were the most effective. All 10 children had a good disease prognosis, and 8 were completely controlled with no recurrence, whereas 2 had less severe and fewer seizures. Conclusion: Mutation of PRRT2 led to a significant decrease in its protein expression level and that of SNAP25, suggesting that the mutant protein may lead to the loss of its function and that of related proteins. This mutation site is highly conserved in most species, and there was no significant correlation between specific PRRT2 genotypes and clinical phenotypes. Asymptomatic carriers also have decreased gene expression levels, suggesting that more factors are involved.

Confirming the Contribution and Genetic Spectrum of De Novo Mutation in Infantile Spasms: Evidence from a Chinese Cohort

Clinical and Molecular Analysis of Epilepsy-Related Genes in Patients with Dravet Syndrome

Mutation and Clinical Characteristics of Autosomal-Dominant Hereditary Spastic Paraplegias in China

A Genomic Copy Number Variant Analysis Implicates the MBD5 and HNRNPUgenes in Chinese Children with Infantile Spasms and Expands the Clinical Spectrum of 2q23.1 Deletion

Diagnostic Yield of a Multi-Strategy Genetic Testing Procedure in a Nationwide Cohort of 728 Patients with Infantile Spasms in China

Molecular characterization of a cohort of 73 patients with infantile spasms syndrome

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases

De Novo Variants in the DYNC1H1 Gene Associated with Infantile Spasms

Genotype and phenotype spectrum of 10 children with STXBP1 gene-related encephalopathy and epilepsy

Etiologic Classification of 541 Infantile Spasms Cases: A Cohort Study

Efficacy of levetiracetam in STXBP1 encephalopathy with different phenotypic and genetic spectra

Gene Mutational Analysis in a Cohort of Chinese Children with Unexplained Epilepsy: Identification of a New KCND3 Phenotype and Novel Genes Causing Dravet Syndrome

[Dynamin-1-related Infantile Spasms: a Case Report and Review of Literature].

Gene Mutation Analysis In 253 Chinese Children With Unexplained Epilepsy And Intellectual/Developmental Disabilities

Analysis of SCN1A mutation and parental origin in patients with Dravet syndrome

A De Novo Splicing Mutation of STXBP1 in Epileptic Encephalopathy Associated with Hypomyelinating Leukodystrophy

Infantile spasms caused by NEXMIF mutation: A case report and literature review

Exome Sequencing of 963 Chinese Families Identifies Novel Epilepsy Candidate Genes

Two novel variants of the STXBP1 and CHRNB2 genes identified in a Chinese boy with refractory seizures and developmental delay

Infantile spasms: Assessing the diagnostic yield of an institutional guideline and the impact of etiology on long‐term treatment response

Germline De Novo Variants in CSNK2B in Chinese Patients with Epilepsy.